热门资讯> 正文
Fortress Biotech 2024财年盈利预览
2025-03-26 05:35
- Fortress Biotech (NASDAQ:FBIO) is scheduled to announce FY earnings results on Wednesday, March 26th, after market close.
The consensus EPS Estimate is -$3.28 (+61.3% Y/Y) and the consensus Revenue Estimate is $58.85M (-30.4% Y/Y).Over the last 2 years, FBIO has beaten EPS estimates 13% of the time and has beaten revenue estimates 38% of the time.
More on Fortress Biotech
- India's Sun Pharma buys onco-derma firm Checkpoint Therapeutics for $355M
- Seeking Alpha’s Quant Rating on Fortress Biotech
- Historical earnings data for Fortress Biotech
- Financial information for Fortress Biotech
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
